Systematic Diabetes Screening Using Point-of-Care HbA<sub>1c</sub> Testing Facilitates Identification of Prediabetes.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 28289117.
- Also identified by DOI 10.1370/afm.2035 and PMC identifier 5348235.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This prospective longitudinal study compares diabetes screenings between standard practices vs systematically offered point-of-care (POC) hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) tests in patients aged 45 years or older. Systematically screened participants (n = 164) identified 63% (n = 104) with unknown hyperglycemia and 53% (n = 88) in prediabetes. The standard practice (n = 324) screened 22% (n = 73), most commonly by blood glucose (96%); 8% (n = 6) and 33% (n = 24) were found to have diabetes and prediabetes, respectively. The association between screening outcome and screening method was statistically significant (<i>P</i> = 0.005) in favor of HbA<sub>1C</sub> HbA<sub>1c</sub> may be the most effective method to identify patients unknowingly living in hyperglycemia. Point-of-care tests further facilitate screening evaluation in a timely and feasible fashion.
Medical subject headings
- Glycated Hemoglobin
- Hyperglycemia
- Mass Screening
- Prediabetic State